Engineered hematopoietic stem cells that unleash the potential of targeted therapies. Hide healthy cells, expose cancer cells.
Total raised: $352M

Investors 2

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
10.02.2021IPO$200M-5amventure...
07.07.2020Series B$110M-5amventure...
14.02.2019Series A$42M-5amventure...

Mentions in press and media 16

DateTitleDescriptionCategoryAuthorSource
10.02.2021Vor Biopha...---5amventure...
17.07.2020Tony Kings...Tony Kings­ley → Schol­ar Roc...-Kathy Wong...endpts.com...
08.07.2020Vor Biopha... CAMBRIDGE, MA, Vor Biopharma...--vcnewsdail...
07.07.2020Vor Biopha...---jnjinnovat...
07.07.2020Vor Biopha...Vor Biopharma, an oncology com...--marketscre...
07.07.2020Vor Biopha...CAMBRIDGE, Mass.--(BUSINESS WI...--citybizlis...
07.07.2020Vor Biopha...---5amventure...
14.02.2019Vor Biopha...Vor Biopharma, a Boston, MA-ba...USA-finsmes.co...
14.02.2019Term Sheet...THE KEY TO A BETTER PARTNERSHI...--fortune.co...
14.02.2019Vor Biopha... BOSTON, MA, Vor Biopharma to...--vcnewsdail...
Show more